Results 271 to 280 of about 387,299 (303)

European Bilberry Extract Ameliorates Dietary Advanced Glycation End Products-Induced Non-Alcoholic Steatohepatitis in Rats via Gut Microbiota and Its Metabolites. [PDF]

Nutrients
Shen L, Cheng R, Chen W, Liu H, Wang X, He R, Mo X, Liu L.   +7 more
europepmc   +1 more source

A New Hope for the Patients of Non-Alcoholic Steatohepatitis: FDA Gives Green Signal for Resmetirom Use. [PDF]

Health Sci Rep
Hasan AH, Abid MA, Abid MH, Suhail L, Nazir A.   +4 more
europepmc   +1 more source

Potential diagnostic marker gene set for non-alcoholic steatohepatitis associated hepatocellular carcinoma with lymphocyte infiltration. [PDF]

Transl Cancer Res
Wang X, Gao M, Zhang Z, Ao X, Luo A, Wen Z, Pan X, Sun M, Wang T, Jia Z.   +9 more
europepmc   +1 more source

Ponatinib alleviates non-alcoholic steatohepatitis through TFEB-mediated autophagy. [PDF]

Front Pharmacol
Lin Z, Yang M, Yu X, Tan G, Zhong J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.

The Lancet Gastroenterology and Hepatology, 2022
BACKGROUND The global burden of non-alcoholic fatty liver disease (NAFLD) parallels the increase in obesity rates across the world. Although overweight and obesity status are thought to be an effective indicator for NAFLD screening, the exact prevalence ...
Jingxuan Quek, Kai E. Chan, Z. Wong, C. Tan, Bryan Tan, W. Lim, D. Tan, A. Tang, Phoebe Tay, J. Xiao, J. Yong, R. Zeng, Nicholas W. S. Chew, Benjamin Nah, A. Kulkarni, M. Siddiqui, Y. Dan, V. Wong, A. Sanyal, M. Noureddin, M. Muthiah, C. Ng   +21 more
semanticscholar   +1 more source

Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

The Lancet Gastroenterology and Hepatology, 2023
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent form of chronic liver disease that poses challenges in diagnosis and risk stratification.
Monica A. Tincopa, R. Loomba
semanticscholar   +1 more source

Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis

Journal of Hepatology, 2021
Background & Aims: Regulatory T-cells (Tregs) impair cancer immunosurveillance by creating an immunosuppressive environment that fosters tumor cell survival.
Han Wang, Hong-Ji Zhang, Yu Wang, Zachary J. Brown, Yujia Xia, Zheng Huang, Cheng-Li Shen, Zhiwei Hu, J. Beane, Ephraim A. Ansa-Addo, Hai Huang, D. Tian, A. Tsung   +12 more
semanticscholar   +1 more source

A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease

Digestive and Liver Disease, 2014
Background: Non-alcoholic fatty liver disease encompasses a spectrum of diseases that range from simple steatosis to the aggressive form of non-alcoholic steatohepatitis. Non-alcoholic steatohepatitis is currently diagnosed through liver biopsy.
Naim Alkhouri, Daniela Liccardo, Ana Rocio Lopez   +2 more
exaly   +2 more sources